Drug Testing Locations - New Lenox, IL

Drug Testing in New Lenox, IL

New Lenox, Illinois Statistics

In 2018, Will County, which includes New Lenox, saw 287 drug overdose deaths.

New Lenox Police recorded 150 drug-related arrests in 2019.

Will County reported a 20% increase in opioid-related deaths from 2018 to 2019.

In 2020, New Lenox saw a 15% decrease in drug possession charges compared to 2019.

The 2021 Illinois Youth Survey indicated rising vaping among teens in Will County.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in New Lenox, IL & Drug Testing Policies

In New Lenox, IL, employers are increasingly adopting stringent drug testing policies to ensure workplace safety. Many local businesses follow federal guidelines, incorporating pre-employment, random, and post-accident testing. These policies help maintain productivity and reduce workplace accidents.

Employers in New Lenox often partner with local health services and testing agencies to facilitate drug screenings. The Substance Abuse and Mental Health Services Administration offers guidelines that many local companies adhere to ensure accuracy and fairness in drug testing processes. Compliance with state law is monitored, and resources are provided by the Illinois Department of Employment Security.

Government Efforts with Drug Problems in New Lenox, IL

The government of New Lenox, IL, in Will County, has initiated various efforts to combat drug problems. These include partnering with the Lincoln-Way Coalition for Preventing Substance Abuse. This initiative focuses on prevention programs for youth and community education events. For more resources, visit the Will County Health Department.

On a state level, Illinois has introduced the Opioid Alternative Pilot Program (OAPP) which allows patients eligible for opioids to opt for medical cannabis instead. This is part of a broader approach to reduce opioid dependence in the state. State resources can be accessed through the Illinois Department of Financial and Professional Regulation.

Local Drug Busts & News in New Lenox, IL

Law enforcement in New Lenox, IL, continues to tackle drug-related crimes aggressively. In a prominent 2022 case, a drug bust led to multiple arrests, disrupting a significant local narcotics operation. The New Lenox Police Department collaborates with regional agencies to counteract drug trafficking.

Community events focused on drug education and prevention are routinely organized in New Lenox. These events aim to raise awareness about the dangers of substance abuse, offering support through local groups such as the Lincoln-Way Area Special Education's 'Say Yes to Life' campaign.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in New Lenox, IL. Trusted by employers nationwide for accurate results and exceptional service.

Illinois DOT/Non DOT Physicals

Illinois Vision Tests

Illinois Audiograms

Illinois Respirator Fit Tests

Illinois Lift Tests

Illinois Background Checks

Clinical Testing Services

TB Testing in IL

Diabetes Testing in IL

Infectious Disease Testing in IL

Sickle Cell Anemia Testing in IL

Women/Men's Health Testing in IL

Resources & Citations

Partnership to End Addiction

Substance Abuse and Mental Health Services Administration

National Institute on Alcohol Abuse and Alcoholism

Illinois Lawyer's Assistance Program

Brighter Futures Indiana

Gateway Foundation

Families Anonymous

Elite Care Health Centers

Drug Testing Near New Lenox, IL

Crest Hill, IL

Lockport, IL

Arbury Hills, IL

Manhattan, IL

Homer, IL

Homer Glen, IL

Preston Heights, IL

Joliet, IL

Frankfort, IL

Mokena, IL

Ingalls Park, IL

Ridgewood, IL

Cherry Hill, IL

Frequently Asked Questions

Customer Reviews